0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Diagnostic Radiopharmaceuticals & Contrast Media Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-30L2144
Home | Market Reports | Health| Pharmacy
Global Diagnostic Radiopharmaceuticals Contrast Media Market Insights Forecast to 2028
BUY CHAPTERS

Global Diagnostic Radiopharmaceuticals & Contrast Media Market Research Report 2024

Code: QYRE-Auto-30L2144
Report
January 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Diagnostic Radiopharmaceuticals & Contrast Media Market Size

The global Diagnostic Radiopharmaceuticals & Contrast Media market was valued at US$ 9776.9 million in 2023 and is anticipated to reach US$ 12190 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030.

Diagnostic Radiopharmaceuticals & Contrast Media Market

Diagnostic Radiopharmaceuticals & Contrast Media Market

North American market for Diagnostic Radiopharmaceuticals & Contrast Media is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Diagnostic Radiopharmaceuticals & Contrast Media is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media include Amag Pharmaceuticals, Bayer Healthcare, Bracco Imaging, Daiichi Sankyo, GE Healthcare, Guerbet, Lantheus, Mallinckrodt and Medtronic, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Diagnostic Radiopharmaceuticals & Contrast Media, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diagnostic Radiopharmaceuticals & Contrast Media.

Report Scope

The Diagnostic Radiopharmaceuticals & Contrast Media market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diagnostic Radiopharmaceuticals & Contrast Media market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diagnostic Radiopharmaceuticals & Contrast Media manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Diagnostic Radiopharmaceuticals & Contrast Media Market Report

Report Metric Details
Report Name Diagnostic Radiopharmaceuticals & Contrast Media Market
Accounted market size in 2023 US$ 9776.9 million
Forecasted market size in 2030 US$ 12190 million
CAGR 3.2%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Radiopharmaceuticals
  • Contrast Media
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amag Pharmaceuticals, Bayer Healthcare, Bracco Imaging, Daiichi Sankyo, GE Healthcare, Guerbet, Lantheus, Mallinckrodt, Medtronic, Nordion
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Diagnostic Radiopharmaceuticals & Contrast Media manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Diagnostic Radiopharmaceuticals & Contrast Media in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Diagnostic Radiopharmaceuticals & Contrast Media Market growing?

Ans: The Diagnostic Radiopharmaceuticals & Contrast Media Market witnessing a CAGR of 3.2% during the forecast period 2024-2030.

What is the Diagnostic Radiopharmaceuticals & Contrast Media Market size in 2030?

Ans: The Diagnostic Radiopharmaceuticals & Contrast Media Market size in 2030 will be US$ 12190 million.

Who are the main players in the Diagnostic Radiopharmaceuticals & Contrast Media Market report?

Ans: The main players in the Diagnostic Radiopharmaceuticals & Contrast Media Market are Amag Pharmaceuticals, Bayer Healthcare, Bracco Imaging, Daiichi Sankyo, GE Healthcare, Guerbet, Lantheus, Mallinckrodt, Medtronic, Nordion

What are the Application segmentation covered in the Diagnostic Radiopharmaceuticals & Contrast Media Market report?

Ans: The Applications covered in the Diagnostic Radiopharmaceuticals & Contrast Media Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Diagnostic Radiopharmaceuticals & Contrast Media Market report?

Ans: The Types covered in the Diagnostic Radiopharmaceuticals & Contrast Media Market report are Radiopharmaceuticals, Contrast Media

1 Diagnostic Radiopharmaceuticals & Contrast Media Market Overview
1.1 Product Overview and Scope of Diagnostic Radiopharmaceuticals & Contrast Media
1.2 Diagnostic Radiopharmaceuticals & Contrast Media Segment by Type
1.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Value Comparison by Type (2024-2030)
1.2.2 Radiopharmaceuticals
1.2.3 Contrast Media
1.3 Diagnostic Radiopharmaceuticals & Contrast Media Segment by Application
1.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size Estimates and Forecasts
1.4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue 2019-2030
1.4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales 2019-2030
1.4.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Diagnostic Radiopharmaceuticals & Contrast Media Market Competition by Manufacturers
2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Manufacturers (2019-2024)
2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price by Manufacturers (2019-2024)
2.4 Global Diagnostic Radiopharmaceuticals & Contrast Media Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, Product Type & Application
2.7 Diagnostic Radiopharmaceuticals & Contrast Media Market Competitive Situation and Trends
2.7.1 Diagnostic Radiopharmaceuticals & Contrast Media Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Diagnostic Radiopharmaceuticals & Contrast Media Players Market Share by Revenue
2.7.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diagnostic Radiopharmaceuticals & Contrast Media Retrospective Market Scenario by Region
3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region: 2019-2030
3.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region: 2019-2024
3.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region: 2025-2030
3.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region: 2019-2030
3.3.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region: 2019-2024
3.3.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region: 2025-2030
3.4 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
3.4.1 North America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2030)
3.4.3 North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
3.5.1 Europe Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2030)
3.5.3 Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
3.6.1 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2030)
3.6.3 Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
3.7.1 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2030)
3.7.3 Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Market Facts & Figures by Country
3.8.1 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2030)
3.8.3 Middle East and Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2019-2030)
4.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2019-2024)
4.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Type (2025-2030)
4.1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2019-2030)
4.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2019-2030)
4.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2019-2024)
4.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Type (2025-2030)
4.2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2019-2030)
4.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Type (2019-2030)
5 Segment by Application
5.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2019-2030)
5.1.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2019-2024)
5.1.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Application (2025-2030)
5.1.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2019-2030)
5.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2019-2030)
5.2.1 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2019-2024)
5.2.2 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Application (2025-2030)
5.2.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2019-2030)
5.3 Global Diagnostic Radiopharmaceuticals & Contrast Media Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Amag Pharmaceuticals
6.1.1 Amag Pharmaceuticals Corporation Information
6.1.2 Amag Pharmaceuticals Description and Business Overview
6.1.3 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.1.5 Amag Pharmaceuticals Recent Developments/Updates
6.2 Bayer Healthcare
6.2.1 Bayer Healthcare Corporation Information
6.2.2 Bayer Healthcare Description and Business Overview
6.2.3 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.2.5 Bayer Healthcare Recent Developments/Updates
6.3 Bracco Imaging
6.3.1 Bracco Imaging Corporation Information
6.3.2 Bracco Imaging Description and Business Overview
6.3.3 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.3.5 Bracco Imaging Recent Developments/Updates
6.4 Daiichi Sankyo
6.4.1 Daiichi Sankyo Corporation Information
6.4.2 Daiichi Sankyo Description and Business Overview
6.4.3 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.4.5 Daiichi Sankyo Recent Developments/Updates
6.5 GE Healthcare
6.5.1 GE Healthcare Corporation Information
6.5.2 GE Healthcare Description and Business Overview
6.5.3 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.5.5 GE Healthcare Recent Developments/Updates
6.6 Guerbet
6.6.1 Guerbet Corporation Information
6.6.2 Guerbet Description and Business Overview
6.6.3 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.6.5 Guerbet Recent Developments/Updates
6.7 Lantheus
6.6.1 Lantheus Corporation Information
6.6.2 Lantheus Description and Business Overview
6.6.3 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.7.5 Lantheus Recent Developments/Updates
6.8 Mallinckrodt
6.8.1 Mallinckrodt Corporation Information
6.8.2 Mallinckrodt Description and Business Overview
6.8.3 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.8.5 Mallinckrodt Recent Developments/Updates
6.9 Medtronic
6.9.1 Medtronic Corporation Information
6.9.2 Medtronic Description and Business Overview
6.9.3 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.9.5 Medtronic Recent Developments/Updates
6.10 Nordion
6.10.1 Nordion Corporation Information
6.10.2 Nordion Description and Business Overview
6.10.3 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product Portfolio
6.10.5 Nordion Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Diagnostic Radiopharmaceuticals & Contrast Media Industry Chain Analysis
7.2 Diagnostic Radiopharmaceuticals & Contrast Media Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Diagnostic Radiopharmaceuticals & Contrast Media Production Mode & Process
7.4 Diagnostic Radiopharmaceuticals & Contrast Media Sales and Marketing
7.4.1 Diagnostic Radiopharmaceuticals & Contrast Media Sales Channels
7.4.2 Diagnostic Radiopharmaceuticals & Contrast Media Distributors
7.5 Diagnostic Radiopharmaceuticals & Contrast Media Customers
8 Diagnostic Radiopharmaceuticals & Contrast Media Market Dynamics
8.1 Diagnostic Radiopharmaceuticals & Contrast Media Industry Trends
8.2 Diagnostic Radiopharmaceuticals & Contrast Media Market Drivers
8.3 Diagnostic Radiopharmaceuticals & Contrast Media Market Challenges
8.4 Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Diagnostic Radiopharmaceuticals & Contrast Media Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Diagnostic Radiopharmaceuticals & Contrast Media, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, Product Type & Application
    Table 12. Global Key Manufacturers of Diagnostic Radiopharmaceuticals & Contrast Media, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Diagnostic Radiopharmaceuticals & Contrast Media by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diagnostic Radiopharmaceuticals & Contrast Media as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2019-2024) & (K Units)
    Table 18. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2019-2024)
    Table 19. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2025-2030) & (K Units)
    Table 20. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2025-2030)
    Table 21. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region (2019-2024)
    Table 23. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region (2025-2030)
    Table 25. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2024) & (K Units)
    Table 27. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2025-2030) & (K Units)
    Table 28. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units) by Type (2019-2024)
    Table 51. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units) by Type (2025-2030)
    Table 52. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2019-2024)
    Table 53. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Type (2025-2030)
    Table 54. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2019-2024)
    Table 57. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Type (2025-2030)
    Table 58. Global Diagnostic Radiopharmaceuticals & Contrast Media Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Diagnostic Radiopharmaceuticals & Contrast Media Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units) by Application (2019-2024)
    Table 61. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units) by Application (2025-2030)
    Table 62. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2019-2024)
    Table 63. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Application (2025-2030)
    Table 64. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2019-2024)
    Table 67. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Application (2025-2030)
    Table 68. Global Diagnostic Radiopharmaceuticals & Contrast Media Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Diagnostic Radiopharmaceuticals & Contrast Media Price (USD/Unit) by Application (2025-2030)
    Table 70. Amag Pharmaceuticals Corporation Information
    Table 71. Amag Pharmaceuticals Description and Business Overview
    Table 72. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Amag Pharmaceuticals Diagnostic Radiopharmaceuticals & Contrast Media Product
    Table 74. Amag Pharmaceuticals Recent Developments/Updates
    Table 75. Bayer Healthcare Corporation Information
    Table 76. Bayer Healthcare Description and Business Overview
    Table 77. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Bayer Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product
    Table 79. Bayer Healthcare Recent Developments/Updates
    Table 80. Bracco Imaging Corporation Information
    Table 81. Bracco Imaging Description and Business Overview
    Table 82. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Bracco Imaging Diagnostic Radiopharmaceuticals & Contrast Media Product
    Table 84. Bracco Imaging Recent Developments/Updates
    Table 85. Daiichi Sankyo Corporation Information
    Table 86. Daiichi Sankyo Description and Business Overview
    Table 87. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Daiichi Sankyo Diagnostic Radiopharmaceuticals & Contrast Media Product
    Table 89. Daiichi Sankyo Recent Developments/Updates
    Table 90. GE Healthcare Corporation Information
    Table 91. GE Healthcare Description and Business Overview
    Table 92. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. GE Healthcare Diagnostic Radiopharmaceuticals & Contrast Media Product
    Table 94. GE Healthcare Recent Developments/Updates
    Table 95. Guerbet Corporation Information
    Table 96. Guerbet Description and Business Overview
    Table 97. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Guerbet Diagnostic Radiopharmaceuticals & Contrast Media Product
    Table 99. Guerbet Recent Developments/Updates
    Table 100. Lantheus Corporation Information
    Table 101. Lantheus Description and Business Overview
    Table 102. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Lantheus Diagnostic Radiopharmaceuticals & Contrast Media Product
    Table 104. Lantheus Recent Developments/Updates
    Table 105. Mallinckrodt Corporation Information
    Table 106. Mallinckrodt Description and Business Overview
    Table 107. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Mallinckrodt Diagnostic Radiopharmaceuticals & Contrast Media Product
    Table 109. Mallinckrodt Recent Developments/Updates
    Table 110. Medtronic Corporation Information
    Table 111. Medtronic Description and Business Overview
    Table 112. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 113. Medtronic Diagnostic Radiopharmaceuticals & Contrast Media Product
    Table 114. Medtronic Recent Developments/Updates
    Table 115. Nordion Corporation Information
    Table 116. Nordion Description and Business Overview
    Table 117. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 118. Nordion Diagnostic Radiopharmaceuticals & Contrast Media Product
    Table 119. Nordion Recent Developments/Updates
    Table 120. Key Raw Materials Lists
    Table 121. Raw Materials Key Suppliers Lists
    Table 122. Diagnostic Radiopharmaceuticals & Contrast Media Distributors List
    Table 123. Diagnostic Radiopharmaceuticals & Contrast Media Customers List
    Table 124. Diagnostic Radiopharmaceuticals & Contrast Media Market Trends
    Table 125. Diagnostic Radiopharmaceuticals & Contrast Media Market Drivers
    Table 126. Diagnostic Radiopharmaceuticals & Contrast Media Market Challenges
    Table 127. Diagnostic Radiopharmaceuticals & Contrast Media Market Restraints
    Table 128. Research Programs/Design for This Report
    Table 129. Key Data Information from Secondary Sources
    Table 130. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Diagnostic Radiopharmaceuticals & Contrast Media
    Figure 2. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Type in 2023 & 2030
    Figure 4. Radiopharmaceuticals Product Picture
    Figure 5. Contrast Media Product Picture
    Figure 6. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Application in 2023 & 2030
    Figure 8. Hospital
    Figure 9. Clinic
    Figure 10. Other
    Figure 11. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size (2019-2030) & (US$ Million)
    Figure 13. Global Diagnostic Radiopharmaceuticals & Contrast Media Sales (2019-2030) & (K Units)
    Figure 14. Global Diagnostic Radiopharmaceuticals & Contrast Media Average Price (USD/Unit) & (2019-2030)
    Figure 15. Diagnostic Radiopharmaceuticals & Contrast Media Report Years Considered
    Figure 16. Diagnostic Radiopharmaceuticals & Contrast Media Sales Share by Manufacturers in 2023
    Figure 17. Global Diagnostic Radiopharmaceuticals & Contrast Media Revenue Share by Manufacturers in 2023
    Figure 18. The Global 5 and 10 Largest Diagnostic Radiopharmaceuticals & Contrast Media Players: Market Share by Revenue in 2023
    Figure 19. Diagnostic Radiopharmaceuticals & Contrast Media Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 20. Global Diagnostic Radiopharmaceuticals & Contrast Media Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 21. North America Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2019-2030)
    Figure 22. North America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2019-2030)
    Figure 23. U.S. Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Canada Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Europe Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2019-2030)
    Figure 26. Europe Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2019-2030)
    Figure 27. Germany Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. France Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. U.K. Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Italy Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Russia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Region (2019-2030)
    Figure 33. Asia Pacific Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Region (2019-2030)
    Figure 34. China Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Japan Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. South Korea Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. India Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Australia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Taiwan Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Indonesia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Thailand Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Malaysia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Philippines Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Diagnostic Radiopharmaceuticals & Contrast Media Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. UAE Diagnostic Radiopharmaceuticals & Contrast Media Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Diagnostic Radiopharmaceuticals & Contrast Media by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Diagnostic Radiopharmaceuticals & Contrast Media by Type (2019-2030)
    Figure 56. Global Diagnostic Radiopharmaceuticals & Contrast Media Price (USD/Unit) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Diagnostic Radiopharmaceuticals & Contrast Media by Application (2019-2030)
    Figure 58. Global Revenue Market Share of Diagnostic Radiopharmaceuticals & Contrast Media by Application (2019-2030)
    Figure 59. Global Diagnostic Radiopharmaceuticals & Contrast Media Price (USD/Unit) by Application (2019-2030)
    Figure 60. Diagnostic Radiopharmaceuticals & Contrast Media Value Chain
    Figure 61. Diagnostic Radiopharmaceuticals & Contrast Media Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Paroxetine Hydrochloride Tablet Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36M7629
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Felodipine Sustained-Release Tablet Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-36A7630
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Sertraline Hydrochloride Tablet Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-25H7597
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Escitalopram Oxalate Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-11E7869
Thu Mar 28 00:00:00 UTC 2024

Add to Cart